TW200606160A - Process for preparation of mycophenolate mofetil and other esters of mycophenolic acid - Google Patents

Process for preparation of mycophenolate mofetil and other esters of mycophenolic acid

Info

Publication number
TW200606160A
TW200606160A TW094113507A TW94113507A TW200606160A TW 200606160 A TW200606160 A TW 200606160A TW 094113507 A TW094113507 A TW 094113507A TW 94113507 A TW94113507 A TW 94113507A TW 200606160 A TW200606160 A TW 200606160A
Authority
TW
Taiwan
Prior art keywords
esters
preparation
mycophenolic acid
mycophenolate mofetil
mofetil
Prior art date
Application number
TW094113507A
Other languages
English (en)
Chinese (zh)
Inventor
Sandor Molnar
Tivadar Tamas
Claude Singer
Csaba Szabo
Janos Hajko
Beata Kosztya
Original Assignee
Teva Gyogyszergyar Reszvenytarsasag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Gyogyszergyar Reszvenytarsasag filed Critical Teva Gyogyszergyar Reszvenytarsasag
Publication of TW200606160A publication Critical patent/TW200606160A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/141111—Diverse hetero atoms in same or different rings [e.g., alkaloids, opiates, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TW094113507A 2004-04-27 2005-04-27 Process for preparation of mycophenolate mofetil and other esters of mycophenolic acid TW200606160A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US56605604P 2004-04-27 2004-04-27
US57298504P 2004-05-20 2004-05-20
US58940004P 2004-07-19 2004-07-19
US63915104P 2004-12-22 2004-12-22
US63847804P 2004-12-23 2004-12-23
US64286705P 2005-01-10 2005-01-10
US66148505P 2005-03-15 2005-03-15

Publications (1)

Publication Number Publication Date
TW200606160A true TW200606160A (en) 2006-02-16

Family

ID=34981904

Family Applications (2)

Application Number Title Priority Date Filing Date
TW094113507A TW200606160A (en) 2004-04-27 2005-04-27 Process for preparation of mycophenolate mofetil and other esters of mycophenolic acid
TW094113530A TWI338006B (en) 2004-04-27 2005-04-27 Mycophenolate mofetil impurity

Family Applications After (1)

Application Number Title Priority Date Filing Date
TW094113530A TWI338006B (en) 2004-04-27 2005-04-27 Mycophenolate mofetil impurity

Country Status (8)

Country Link
US (3) US20050250773A1 (enExample)
EP (2) EP1675841A1 (enExample)
JP (2) JP2007534697A (enExample)
CA (2) CA2555454C (enExample)
IL (2) IL175517A0 (enExample)
MX (2) MXPA06005658A (enExample)
TW (2) TW200606160A (enExample)
WO (2) WO2005105769A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005105768A2 (en) 2004-04-26 2005-11-10 Teva Gyógyszergyár Zàrtköruen Muködo Rèszvènytàrsasàg Process for preparation of mycophenolic acid and ester derivatives thereof
MXPA06005658A (es) * 2004-04-27 2007-04-10 Teva Gyogyszergyar Zartkoruen Proceso para preparacion de micofenolato mofetil, y otros esteres de acido micofenolico.
WO2006076802A1 (en) * 2005-01-20 2006-07-27 Apotex Fermentation Inc. An improved process for the preparation of mycophenolate mofetil
ATE489370T1 (de) * 2005-06-14 2010-12-15 Schering Corp Herstellung und verwendung von verbindungen als aspartylproteasehemmer
PL2032712T3 (pl) * 2006-06-29 2010-07-30 Ivax Pharmaceuticals Sro Regulacja wytwarzania kwaśnego metabolitu
CN1974564B (zh) * 2006-12-15 2010-05-12 丽珠集团新北江制药股份有限公司 一种霉酚酸莫啡酯的制备方法
US20080188653A1 (en) 2007-02-04 2008-08-07 Formosa Laboratories, Inc. Process for Preparation of Mycophenolate Mofetil
MX2008015797A (es) * 2007-04-11 2009-03-06 Teva Gyogyszergyar Zartkoeruen Metodo para reducir el nivel de impurezas en la fermentacion del acido micofenolico.
WO2008125616A2 (en) * 2007-04-12 2008-10-23 Dsm Ip Assets B.V. Method for the purification of bio-molecules
WO2009010503A1 (en) * 2007-07-18 2009-01-22 Dsm Ip Assets B.V. Mycophenolic acid recycling in a method for the preparation of mycophenolate mofetil
CN105510496B (zh) * 2015-11-25 2017-06-16 宜昌东阳光长江药业股份有限公司 一种富马酸卢帕他定原料药合成工艺中dmf残留的测定方法
CN107727605A (zh) * 2016-08-11 2018-02-23 立邦涂料（中国）有限公司 一种分析矿物油类消泡剂的新方法
CN113549040B (zh) * 2020-04-23 2024-08-06 鲁南制药集团股份有限公司 一种吗替麦考酚酯杂质d的制备方法
CN112710752A (zh) * 2020-12-18 2021-04-27 卓和药业集团有限公司 麦考酚钠残留溶剂的检测方法
CN116500172B (zh) * 2023-06-29 2023-09-05 成都普康唯新生物科技有限公司 一种酸性底物中胺类溶剂的检测方法
CN118330068B (zh) * 2024-04-16 2026-05-01 中国热带农业科学院分析测试中心 一种检测农产品复杂基质中盐酸吗啉胍的方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1157099A (en) 1966-09-27 1969-07-02 Ici Ltd Fermentation Process
GB1158387A (en) 1967-06-13 1969-07-16 Ici Ltd Procedure for Isolation of Mycophenolic Acid
ZA684959B (en) 1967-11-22 1969-05-22 Lilly Co Eli Agents and methods for inhibiting the growth of malignant tumor cells in warm-blooded mammals
US4452891A (en) * 1980-09-08 1984-06-05 Ajinomoto Company Incorporated Method for production of mycophenolic acid by fermentation
US4861776A (en) * 1987-01-30 1989-08-29 Syntex (U.S.A) Inc. Heterocyclic aminoalkyl esters of mycophenolic acid and derivatives thereof, compositions and use
US4748173A (en) * 1987-01-30 1988-05-31 Syntex (U.S.A.) Inc. Heterocyclic aminoalkyl esters of mycophenolic acid and derivatives thereof and pharmaceutical compositions
US4753935A (en) * 1987-01-30 1988-06-28 Syntex (U.S.A.) Inc. Morpholinoethylesters of mycophenolic acid and pharmaceutical compositions
US5247083A (en) 1992-07-10 1993-09-21 Syntex (U.S.A.) Inc. Direct esterification of mycophenolic acid
US5455045A (en) * 1993-05-13 1995-10-03 Syntex (U.S.A.) Inc. High dose formulations
BR9407469A (pt) * 1993-09-15 1996-11-12 Syntex Inc Micofenolato mofetil anidro cristalino e formulação intravenosa do mesmo
PL177323B1 (pl) * 1993-10-01 1999-10-29 Syntex Inc Kompozycja farmaceutyczna zawierająca mykofenolan mofetylu lub kwas mykofenolowy i sposób wytwarzania kompozycji farmaceutycznej zawierającej mykofenolan mofetylu lub kwas mykofenolowy
ID18663A (id) 1996-04-12 1998-04-30 Novartis Ag Komposisi farmasi berlapis enterik
GB9812413D0 (en) 1998-06-10 1998-08-05 Glaxo Group Ltd Compound and its use
IN188985B (enExample) * 1998-12-09 2002-11-30 Biocon Ltd
HUP9903226A2 (en) 1999-09-23 2002-08-28 Gyogyszerki Process for producing mycophenolic acid and derivatives thereof
JP2003525052A (ja) 2000-02-29 2003-08-26 バイオコン・インディア・リミテッド マイコフェノール酸の製造および精製
CZ292123B6 (cs) 2001-06-08 2003-08-13 Ivax Pharmaceuticals S.R.O. Způsob přípravy mykofenolátu mofetilu
US6706846B2 (en) * 2001-10-10 2004-03-16 General Electric Company Method for end-capping polycarbonate resins and composition for use in same
AU2002334381B2 (en) 2002-08-29 2007-01-04 Biocon Limited Process for the production of an immunosuppressant
GB0301259D0 (en) 2003-01-20 2003-02-19 Novartis Ag Organic compounds
TWI221414B (en) * 2003-02-21 2004-10-01 Chunghwa Chemical Synthesis & Method of making mycophenolate mofetil using transesterification
GB0307553D0 (en) 2003-04-01 2003-05-07 Novartis Ag Organic compounds
MXPA06005658A (es) * 2004-04-27 2007-04-10 Teva Gyogyszergyar Zartkoruen Proceso para preparacion de micofenolato mofetil, y otros esteres de acido micofenolico.
US20080281111A1 (en) * 2005-04-26 2008-11-13 Sandor Molnar Process for preparation of mycophenolate mofetil and other esters of mycophenolic acid

Also Published As

Publication number Publication date
IL175517A0 (en) 2006-09-05
IL175516A0 (en) 2006-09-05
US20080241948A1 (en) 2008-10-02
JP2007534697A (ja) 2007-11-29
WO2005105769A3 (en) 2006-03-30
MXPA06005658A (es) 2007-04-10
CA2555454A1 (en) 2005-11-10
WO2005105771A1 (en) 2005-11-10
CA2555454C (en) 2009-12-15
US20050282806A1 (en) 2005-12-22
CA2555461A1 (en) 2005-11-10
US7358247B2 (en) 2008-04-15
US20050250773A1 (en) 2005-11-10
JP2007522117A (ja) 2007-08-09
EP1740563A2 (en) 2007-01-10
EP1675841A1 (en) 2006-07-05
TW200614994A (en) 2006-05-16
MXPA06005660A (es) 2007-04-10
TWI338006B (en) 2011-03-01
WO2005105769A2 (en) 2005-11-10

Similar Documents

Publication Publication Date Title
IL185031A0 (en) Method for the preparation of pregabalin and salts thereof
WO2005120524A3 (en) Nutritional formulations
EP2450360A3 (en) (S)-N-Methylnaltrexone
TW200617172A (en) Enzymatic preparation of (meth)acrylic esters
WO2005094235A3 (en) Toasted soybean flakes and method of making same
WO2006127899A3 (en) (r)-n-methylnaltrexone, processes for its synthesis and its pharmaceutical use
IL179251A0 (en) Cell lines and processes utilizing the same for the production of an influenza vaccine
DE60143084D1 (de) Verfahren zur herstellung von glyceriden mittels lipasen
CA2713943C (en) Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
IL175516A0 (en) Process for preparation of mycophenolate mofetil and other esters of mycophenolic acid
ATE482966T1 (de) Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide
WO2008027600A3 (en) Imatinib compositions
WO2009036204A3 (en) Phase ii detoxification and antioxidant activity
WO2007044950A3 (en) Crystalline forms of docetaxel and processes for their preparation
WO2006000547A3 (de) Verfahren zur herstellung eines phosphatadsorbens auf eisensulfat-basis
EP1668125A4 (en) MODIFIED ENZYMES, PROCESSES FOR PRODUCING MODIFIED ENZYMES AND USES THEREOF
WO2006012379A3 (en) Processes for preparation of crystalline mycophenolate sodium
WO2008067408A3 (en) Method of isolating and propagating stem cells from benign tumors
WO2005105768A3 (en) Process for preparation of mycophenolic acid and ester derivatives thereof
WO2005075412A3 (en) Norbornane based cycloaliphatic compounds containing nitrile groups
WO2007141593A3 (en) Process for the preparation of metoprolol and its salts
DE50312796D1 (de) Verfahren zur herstellung von isocyanaten
WO2008013995A3 (en) Tridesmethylvenlafaxine and processes for the synthesis of o-desmethylvenlafaxine
WO2008025028A3 (en) Method for preparing polyester nanocomposites
IL180311A0 (en) Process for the preparation of 4,4-difluoro-3-oxobutanoic acid esters